SunPharma gets USFDA nod for generic form of Novartis' Gleevec
Drug major Sun Pharmaceutical Industries today said one of its subsidiaries has received USFDA approval to manufacture and market generic version of Novartis' Gleevec, used in treatment of cancer, in America.
Dec 04, 2015, 12:38 PM IST